LEVIN ARTHUR A (CIK 1181556) reported 13 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-03-17). Recent activity: Sell STOK (605 shares), Sell RNAM (16,562 shares), Sell RNAM (131,372 shares), Sell RNA (1,758 shares), Buy STOK (1,211 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | Director | Sell | 605 | $22,264 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Director | Sell | 16,562 | $0 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Director | Sell | 131,372 | $0 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 1,758 | $127,367 |
| 2026-01-05 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 1,211 | $0 |
| 2025-12-22 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 1,330 | $0 |
| 2025-10-01 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 1,211 | $0 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Buy | 107,500 | $2.4M |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 107,500 | $5.1M |
| 2025-07-02 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 1,210 | $0 |
| 2025-06-12 | Avidity Biosciences, Inc. (RNA) | Director | Buy | 6,692 | $0 |
| 2025-04-02 | Stoke Therapeutics, Inc. (STOK) | Director | Buy | 1,210 | $0 |
| 2025-01-23 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 1,872 | $53,539 |
Source: SEC Form 4 filings · as of 2026-03-17